EPO neem patent revocation revives biopiracy debate

  title={EPO neem patent revocation revives biopiracy debate},
  author={Cormac Sheridan},
  journal={Nature Biotechnology},
  • C. Sheridan
  • Published 1 May 2005
  • Engineering
  • Nature Biotechnology
Traditional knowledge exploited by biotech companies warrants some compensation. 
Justice and Benefit Sharing
Benefit sharing as envisaged by the Convention on Biological Diversity (CBD) is a relatively new idea in international law. In the context of non-human biological resources, it aims to guarantee the
Biopiracy after the Nagoya Protocol: Problem Structure, Regime Design and Implementation Challenges
This article assesses the effectiveness of the 2010 Nagoya Protocol to the Convention on Biological Diversity (CBD) for addressing "biopiracy" of genetic resources; that is, their biotechnological
Commutative Justice and Access and Benefit Sharing for Genetic Resources
Abstract The Convention on Biological Diversity (CBD) and its Nagoya Protocol (NP) established an Access and Benefit Sharing (ABS) system between utilizers and providers of genetic resources. ABS is
Since the first ever patent on a genetically modified organism was granted in 1980 in the US, hundreds of attempts on patenting life forms including human disease genes have been made and many have
Biological Diversity in the Patent System
It is concluded that the narrow focus of human innovative activity and ownership of genetic resources is unlikely to be in the long term interest of humanity and a broader spectrum of biodiversity needs to be opened up to research and development based on the principles of equitable benefit-sharing.
Justice and the Convention on Biological Diversity
Justice and the Convention on Biological Diversity Doris Schroeder and Thomas Pogge Benefit sharing as envisaged by the 1992 Convention on Biological Diversity (CBD) is a relatively new idea in
Legal Frameworks for Benefit Sharing: From Biodiversity to Human Genomics
The philosophical principle behind benefit sharing is simple. Those who contribute to scientific research ought to share in its benefits. This is a matter of justice. If benefit sharing does not take
Eric Deibel 3.qxp
This article examines property relations in biotechnology by looking at open source in the sub-disciplines of genomics and bio-informatics within the context established interpretations of common
Interpretation and Application of International Legal Obligation in a National Legal System: Taking Seriously Benefit Sharing from the Utilization of Genetic Resources in India
In taking seriously the interpretation and application of international obligations on sharing of benefits equitably on genetic resources, India has decided for a law, rules and guidelines to define
Advancing urban ethnopharmacology: a modern concept of sustainability, conservation and cross-cultural adaptations of medicinal plant lore in the urban environment
The potential of urban ethnopharmacology and medicinal plants from the anthropologist and religious viewpoints are presented and the emergence and the present status of urban archaeology throughout the globe have been critically reviewed.


Kenyan dispute illuminates bioprospecting difficulties
Even when going by the book, biotech firms can ruffle feathers in developing countries.